FDA OKs implant for enlarged prostate symptoms

(AP)—Federal health regulators have approved the first permanent implant to treat men's urinary problems caused by an enlarged prostate.

The Food and Drug Administration says it approved the Urolift system to relieve low or blocked urine flow in men age 50 or older. The implant works by holding back that presses against the urethra, causing difficulty urinating.

More than half of men in their sixties have some due to enlarged prostate, including frequent urination, weak stream and leaking. Current treatment options include drug therapy and surgery to remove part of the prostate. The Urolift is implanted by a doctor using a handheld device that is inserted through the urethra.

Side effects reported in company trials include pain during urination, blood in urine and decreased urine flow.

© 2013 The Associated Press. All rights reserved.

Citation: FDA OKs implant for enlarged prostate symptoms (2013, September 13) retrieved 19 March 2024 from https://medicalxpress.com/news/2013-09-fda-oks-implant-enlarged-prostate.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Shape of urine stream can indicate prostate issues

 shares

Feedback to editors